Talphera (TLPH) Non-Current Assets (2010 - 2026)
Talphera (TLPH) posted quarterly Non-Current Assets of $8.8 million for Q1 2026, little changed year-over-year from $8.8 million in Q1 2025, and little changed quarter-over-quarter from $8.8 million in Q4 2025.
Talphera (TLPH) Non-Current Assets (2010 - 2026) Analysis & Trends
Talphera's Non-Current Assets history runs 17 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- In Q1 2026, Non-Current Assets changed 0.0% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $35.3 million (changed 0.0% YoY), while the FY2025 annual figure was $8.8 million, changed 0.0% from the prior year.
- Non-Current Assets for Q1 2026 stood at $8.8 million, roughly flat from $8.8 million in the prior quarter.
- The five-year high for Non-Current Assets was $29.2 million in Q1 2022, with the low at $8.8 million in Q4 2023.
- The 5-year median for Non-Current Assets is $8.8 million (2023), against an average of $12.6 million.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets soared 81.89% in 2022, then slumped 69.35% in 2023.
- Talphera's Non-Current Assets stood at $22.9 million in 2022, then tumbled by 61.52% to $8.8 million in 2023, then changed by 0.0% to $8.8 million in 2024, then changed by 0.0% to $8.8 million in 2025, then changed by 0.0% to $8.8 million in 2026.
- Business Quant data shows TLPH's Non-Current Assets at $8.8 million in Q1 2026, $8.8 million in Q4 2025, and $8.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 2.96 Bn |
| 10 | Talphera | 89.88 Mn | 89.88 Mn | - | 8.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.82 Mn |
| Mar 31, 2026 | 8.82 Mn |
| Dec 31, 2025 | 8.82 Mn |
| Sep 30, 2025 | 8.82 Mn |
| Jun 30, 2025 | 8.82 Mn |
| Mar 31, 2025 | 8.82 Mn |
| Dec 31, 2024 | 8.82 Mn |
| Sep 30, 2024 | 8.82 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Mar 31, 2024 | 8.82 Mn |
| Dec 31, 2023 | 8.82 Mn |
| Sep 30, 2023 | 8.84 Mn |
| Jun 30, 2023 | 8.89 Mn |
| Mar 31, 2023 | 8.94 Mn |
| Dec 31, 2022 | 22.92 Mn |
| Sep 30, 2022 | 23.77 Mn |
| Jun 30, 2022 | 24.14 Mn |
| Mar 31, 2022 | 29.16 Mn |
| Dec 31, 2021 | 27.40 Mn |
| Sep 30, 2021 | 20.51 Mn |